Skip to content

Danis Pharma

Active Public limited companyfounded 1999active for 27 yearsDanislaan 13, 1650 BeerselKBO/BCE: BE 0465.345.721 subsidiary of

Timeline

40 events since 1999

The 2026 accounts are due by 31-01-2027.

2026
Annual accounts 2025 filed PDFabbreviated format · 2 days before the deadline
2025
Annual accounts 2024 filed PDFabbreviated format · 21 days late
2024
Annual accounts 2023 filed PDFabbreviated format · 1 day before the deadline
(director) and (director) reappointedGeneral meeting of 21-12-20236 points ▸
  • Director reappointment,
  • Director reappointment,
  • Power of attorney,
  • Power of attorney,
  • General meeting, 21-12-2023
  • Capital, €61,973.38, 250 shares
  • The deed holds 6 more points.

Open the deed in the Belgian Official Gazette

2023
Annual accounts 2022 filed PDFabbreviated format · 1 day before the deadline
2022
Highest result from 2007 to 2025 net €100,954 ▲3.5% The operating result of €144,132 and the net result of €100,954 are both a record.
Equity above €500,000 equity €556,995 ▲22.1% After 3 profitable years in a row, equity reaches €556,995.
2021
Annual accounts 2021 filed PDFabbreviated format · 41 days before the deadline
Annual accounts 2020 filed PDFabbreviated format · 2 days before the deadline
2020
Back to profit net €71,557 The net result is €71,557, after one loss-making year.
Annual accounts 2019 filed PDFabbreviated format · 10 days before the deadline
2019
Weakest financial year net -€31,065 The net result drops to -€31,065, the lowest from 2007 to 2025. It recovers the following year.
(director) and (managing director) reappointedGeneral meeting of 02-12-20175 points ▸
  • General meeting, 02-12-2017
  • Director reappointment,
  • Director reappointment,
  • Board meeting, 02-12-2017
  • Director reappointment, (managing director)

Open the deed in the Belgian Official Gazette

Annual accounts 2018 filed PDFabbreviated format · 13 days before the deadline
2018
Back to profit net €42,455 The net result is €42,455, after one loss-making year.
Annual accounts 2017 filed PDFabbreviated format · 29 days before the deadline
2016
Annual accounts 2016 filed PDFabbreviated format · 50 days before the deadline
Annual accounts 2015 filed PDFabbreviated format · 9 days before the deadline
2014
Annual accounts 2014 filed PDFabbreviated format · 64 days before the deadline
Equity above €200,000 equity €215,093 ▲20.8% After 6 profitable years in a row, equity reaches €215,093.
Annual accounts 2013 filed PDFabbreviated format · 20 days late
2013
Annual accounts 2012 filed PDFabbreviated format · 28 days late
2012
Equity above €150,000 equity €159,387 ▲14.9% After 4 profitable years in a row, equity reaches €159,387.
Annual accounts 2011 filed PDFabbreviated format · 23 days late
1 director appointed, 1 resignation changes role from director to managing director · resigns · appointed10 points ▸
  • Capital, €61,973.38
  • Director resignation,
  • Director resignation,
  • Director discharge,
  • Director discharge,
  • Director appointment,
  • Director appointment,
  • Director appointment, (managing director)
  • Power of attorney,
  • Capital, €61,973.38, 250 shares
  • The deed holds 3 more points.

Open the deed in the Belgian Official Gazette

2011
Annual accounts 2010 filed PDFabbreviated format · 36 days late
2010
Equity above €100,000 equity €112,123 ▲13.9% After 2 profitable years in a row, equity reaches €112,123.
Annual accounts 2009 filed PDFabbreviated format · 1 day late
2009
Back to profit net €17,002 The net result is €17,002, after one loss-making year.
2008
Annual accounts 2008 filed PDFabbreviated format · 33 days before the deadline
Annual accounts 2007 filed PDFabbreviated format · on the deadline day
2007
Annual accounts 2006 filed PDFabbreviated format · 2 days before the deadline
2006
Annual accounts 2005 filed PDFabbreviated format
2005
Annual accounts 2004 filed PDFabbreviated format
2004
Annual accounts 2003 filed PDFabbreviated format
2003
Annual accounts 2002 filed PDFabbreviated format
2001
Annual accounts 2001 filed PDFabbreviated format
Annual accounts 2000 filed PDFabbreviated format
2000
First establishment Danislaan 13, Beersel
1999
Incorporation published on 04-02-1999

Financial milestones sit on the financial year-end date, not the filing date.

Sources: Publications in the Belgian Official GazetteFilings with the National Bank

History

Danis Pharma was incorporated on 27 January 1999.1 Total assets rose from €432,332 in 2019 to €866,100 in 2025.2

  1. 1KBO register
  2. 2National Bank, annual accounts 2019 and 2025

Next steps